Stock 600332 GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Shanghai S.E.

Equities

600332

CNE000001733

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-17 pm EDT 		5-day change 1st Jan Change
30.7 CNY +1.22% Intraday chart for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited +6.75% +7.34%
Mar. 18 Baiyunshan Pharmaceutical's 2023 Profit Rises 2% MT
Mar. 15 Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Announces Final Ordinary Dividend for the Year Ended 31 December 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Baiyunshan Pharmaceutical's 2023 Profit Rises 2%
MT
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Announces Final Ordinary Dividend for the Year Ended 31 December 2023
CI
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Baiyunshan Pharma's Unit Gets Green Light to Produce Hepatitis B Drug
MT
Guangzhou Pharma Unit Gets Green Light to Trial Oral Liquid Drug
MT
Guangzhou Baiyunshan Pharmaceutical Arm Floats 1 Billion Yuan Biomedical VC Fund
MT
Guangzhou Baiyunshan Pharmaceutical Ends Spin-Off Plans, Seeks China Listing for Subsidiary
MT
Guangzhou Pharma Expands Scope of Drug Production License
MT
Guangzhou Baiyunshan Pharmaceutical's Profit Up 11% in Q3
MT
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Baiyunshan Pharmaceutical Reports Increase in H1 Attributable Profit
MT
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Ex-dividend day for final dividend
FA
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(SHSE:600332) added to Shanghai Stock Exchange 180 Value Index
CI
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(SHSE:600332) added to SSE 180 Index
CI
Guangzhou Pharma Registers Pain-Relief, Anti-Inflammatory Drugs in Russia
MT
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the First Quarter Ended March 30, 2023
CI
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Announces Election of the Supervisor Representing the Employees of the 9th Session of the Supervisory Committee
CI
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Announces Final Dividend for the Year Ended 31 December 2022
CI
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 874 Stock
  4. 600332 Stock
  5. News Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited